and cash flow into account to uncover stocks that will see long-term, sustainable growth. Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

WASHINGTON (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden administration ...

The number one nutrient to reduce insulin resistance is dietary fiber, primarily because of the way it helps slow digestion ...

On Monday, the S&P 500 eclipsed the coveted 6,000 mark, banking on the post-election rally. Donald Trump’s election victory ...

Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...

The stocks for both Swiss and Israeli biotechs were up over 20% after the companies signed a merger agreement.

She could drive to a town 90 minutes away where another Fred Meyer had two vials in stock or call other pharmacies to see what she could drum up. "I'm desperate. I need my insulin, and I need it ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.